Pulmonx (LUNG) EPS (Basic) Growth (1y) (2020 - 2025)
Pulmonx (LUNG) EPS (Basic) Growth (1y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.61 Bn | 194.01 Bn | 7.27 Bn | -47.75% |
| 2 | Stryker | 127.81 Bn | 124.34 Bn | 4.50 Bn | 43.85% |
| 3 | Medtronic | 119.04 Bn | 109.82 Bn | 6.41 Bn | 18.90% |
| 4 | Boston Scientific | 73.68 Bn | 73.14 Bn | 3.85 Bn | 14.55% |
| 5 | Edwards Lifesciences | 51.96 Bn | 47.71 Bn | 1.35 Bn | -25.84% |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | 42.13% |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 15.81% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 72.17% |
| 9 | Steris | 23.06 Bn | 22.58 Bn | 684.20 Mn | 13.85% |
| 10 | Pulmonx | 93.95 Mn | 24.20 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 5.38% |
| Jun 30, 2025 | 4.59% |
| Mar 31, 2025 | -1.51% |
| Dec 31, 2024 | 8.16% |
| Sep 30, 2024 | 8.07% |
| Jun 30, 2024 | 8.00% |
| Mar 31, 2024 | 15.61% |
| Dec 31, 2023 | 5.01% |
| Sep 30, 2023 | -2.86% |
| Jun 30, 2023 | -8.24% |
| Mar 31, 2023 | 2.05% |
| Dec 31, 2022 | -7.03% |
| Sep 30, 2022 | -36.43% |
| Jun 30, 2022 | -9.84% |
| Mar 31, 2022 | -21.50% |
| Dec 31, 2021 | 60.56% |
| Sep 30, 2021 | 79.63% |
| Jun 30, 2021 | 94.17% |
| Mar 31, 2021 | 90.56% |
| Dec 31, 2020 | 65.31% |